Table 3.
Demographic and pre-treatment clinical variables according to type of transfusions given in those ≤50 years of age.
| ABO Matched, Leukoreduced | ABO Matched, Leukoreduced, Washed | P value by Mann Whitney or Fisher's Exact Test | |
| N | 10 | 12 | |
| Age | 30 ± 9.4 | 32 ± 9.5 | 0.77 |
| Male | 5 (50%) | 6 (50%) | 1.00 |
| ALL/AML | 1/9 | 4/8 | 0.32 |
| Antecedent Hematologic Disorder (MDS) | 0 of 10 (0%) | 0 of 12 (0%) | 1.00 |
| Favorable Risk Cytogenetics | 0 (0%) | 0 (0%) | 0.09 |
| Standard Risk Cytogenetics | 5 (33%) | 2 (28%) | |
| Poor Risk Cytogenetics | 1 (11%) | 6 (44%) | |
| Unknown Cytogenetics | 4 (50%) | 4 (28%) | |
| Admission Blast Count (×1000/μl) | 29 ± 49 | 29 ± 49 | 0.56 |
All data are mean ± 1 SD. MDS = myelodysplastic syndrome